| Literature DB >> 27425144 |
Esther Nuebel1, Phanee Manganas1, Kostas Tokatlidis2.
Abstract
The mitochondrial intermembrane space (IMS) is involved in protein transport, lipid homeostasis and metal ion exchange, while further acting in signalling pathways such as apoptosis. Regulation of these processes involves protein modifications, as well as stress-induced import or release of proteins and other signalling molecules. Even though the IMS is the smallest sub-compartment of mitochondria, its redox state seems to be tightly regulated. However, the way in which this compartment participates in the cross-talk between the multiple organelles and the cytosol is far from understood. Here we focus on newly identified IMS proteins that may represent future challenges in mitochondrial research. We present an overview of the import pathways, the recently discovered new components of the IMS proteome and how these relate to key aspects of cell signalling and progress made in stem cell and cancer research.Entities:
Keywords: Intermembrane space; Metabolism; Mitochondria; Mitochondrial proteome; Protein import; Redox signalling
Mesh:
Substances:
Year: 2016 PMID: 27425144 PMCID: PMC5404111 DOI: 10.1016/j.bbamcr.2016.07.004
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002
Summary of the newly identified protein members of the intermembrane space proteome. Assignment of gene names and accession numbers was achieved by following annotations from UniProt/SGD. Cell compartment annotation as summarized in the table is based on evidence found in specific literature. The “Yeast/Human homolog” column refers to the homologous yeast proteins in the case of the human proteome and the homologous human proteins in the case of the yeast proteome. The “Mitochondrial/IMS localisation verified” column refers to the proteins that have been verified experimentally (western blotting or fluorescence microscopy) to have a mitochondrial localisation for the human proteome or an IMS specific localisation for the yeast proteome. (* Laminin contains a very large number of both typical (eg. CX9C) and non-typical (eg. CX5C) cysteine motifs).
| UniProt accession number | Protein names | Gene names | Yeast/ human homolog | Molecular weight (kDa) | CXnC motif | Previous | Mitochondrial/ |
|---|---|---|---|---|---|---|---|
| Mycophenolic acid acyl-glucuronide esterase, mitochondrial | ABHD10 | – | 33.9 | CX6C, CX9C | – | No | |
| Lysophosphatidic acid phosphatase type 6 | ACP6 | – | 48.9 | CX7C, CX4C | Mitochondria [1] | No | |
| Acylglycerol kinase, mitochondrial | AGK, MULK | – | 47.1 | CX13CX8C, CX5C | Mitochondrial membrane [2] | No | |
| MICOS complex subunit MIC26 | APOO, | – | 22.3 | CX6C | ER/Golgi, inner mitochondrial membrane [3] | Yes [4] | |
| Coiled-coil domain-containing protein 127 | CCDC127 | – | 30.8 | – | – | Yes [4] | |
| Coiled-coil domain-containing protein 58 | CCDC58 | – | 16.6 | – | – | No | |
| Protein CCSMST1 | CCSMST1 | – | 15.0 | CX8C | – | No | |
| M-phase inducer phosphatase 3 | CDC25C | – | 53.4 | CX6CX16C, CX7C, CX10CXC, CX5CX13C | Nucleus [5] | Yes [4] | |
| Protein CEBPZOS | CEBPZOS | – | 9.3 | – | – | Yes [4] | |
| Caseinolytic peptidase B protein homolog | CLPB, HSP78, SKD3 | – | 75.4 | CX9C | Mitochondria [6] | No | |
| COX assembly mitochondrial protein 2 homolog | CMC2, C16orf61 | CMC2 | 9.5 | Twin CX9C | Inner membrane facing IMS [7] | No | |
| Cytochrome c oxidase assembly factor 6 homolog | COA6, C1orf31 | COA6 | 14.1 | CX12C, CX9CX10CX11C | – | Yes [8] | |
| Cytochrome c oxidase assembly factor 7 | COA7, RESA1 | – | 25.7 | CX3CX8C, CX8C, CX4CX10C, CX7C, CX6CX7C | – | Yes [4,9] | |
| Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial | COX16, C14orf112 | COX16 | 12.3 | – | Mitochondrial membrane [10] | No | |
| Cytochrome c oxidase protein 20 homolog | COX20, FAM36A | COX20 | 13.3 | CX13CX3C | – | No | |
| Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial | DLST, DLTS | KGD2 | 48.8 | CX16CX12C | – | No | |
| Protein FAM136A | FAM136A | – | 26.8 | CX9C, CX3CC, triple CX3C | – | No | |
| Protein FAM162A | FAM162A, C3orf28 | – | 17.3 | CX3C | – | No | |
| Peptidyl-prolyl cis-trans isomerase FKBP10 | FKBP10 | FPR2 | 64.2 | CX15C | – | Yes [4] | |
| Heme-binding protein 1 | HEBP1, HBP | – | 21.1 | – | Cytosol [11] | No | |
| Laminin subunit gamma-1 | LAMC1 | – | 177.6 | CXnC* | – | No | |
| Microsomal glutathione S-transferase 3 | MGST3 | – | 16.5 | – | – | Yes [4] | |
| Coiled-coil-helix-coiled-coil-helix domain-containing protein 2, mitochondrial; Aging-associated gene 10 protein | MNRR1, CHCHD2, AAG10, C7orf17 | MIX17 | 15.5 | CX9CX9CX9C | Nucleus [12], mitochondria [13] | No | |
| Next to BRCA1 gene 1 protein | NBR1 | – | 107.4 | CX2CX10CX2CX5CX2C | Cytosol [14] | Yes [4] | |
| Nucleobindin-2 | NUCB2, | – | 50.2 | CX5C | Golgi apparatus [15] | No | |
| OCIA domain-containing protein 1, Ovarian carcinoma immunoreactive antigen | OCIAD1, OCIA | – | 27.6 | CX14C | – | No | |
| Protein disulfide-isomerase | P4HB | PDI1 | 57.1 | Twin CX2C | ER [16,17] | No | |
| Prostaglandin E synthase 2 | PGES2, C9orf15 | – | 41.9 | CX2C | Golgi apparatus membrane [18] | No | |
| Thioredoxin-dependent peroxide reductase, mitochondrial | PRDX3, AOP1 | TSA1 | 27.7 | CX9CX14C | – | Yes [19] | |
| Peroxiredoxin-4 | PRDX4 | TSA1 | 30.5 | – | Cytosol [20] | No | |
| Reticulocalbin-2 | RCN2, ERC55 | – | 36.9 | – | – | No | |
| Regulator of microtubule dynamics protein 1 | RMDN1, FAM82B | – | 35.8 | CX2C | – | No | |
| Protein SERAC1 | SERAC1 | – | 74.1 | CX2CC, CX13C, CX9C | Mitochondria-ER interface [21] | No | |
| Synaptosomal-associated protein 29 | SNAP29 | – | 29.0 | – | Cytosol [22] | No | |
| StAR-related lipid transfer protein 7, mitochondrial | STARD7, GTT1 | – | 43.1 | – | – | No | |
| Syntaxin-17 | STX17 | – | 33.4 | CX10C | ER, ERGIC | Yes [4] | |
| Thioredoxin domain-containing protein 12, ERp18 | TXNDC12 | – | 19.2 | CX2C | ER [24] | No | |
| Cytochrome c oxidase assembly factor 6 | COA6 (YMR244C-A) | COA6 | 12.4 | CX9C, CX10C | – | Yes [8,25] | |
| Cytochrome c oxidase assembly protein COX11, mitochondrial | COX11 (YPL132W) | COX11 | 34.0 | CXC | Mitochondrial membrane [26] | No | |
| Subunit VIB of cytochrome c oxidase | COX12 (YLR038C) | COX6B2 | 9.8 | CX9C, CX10C | Integral to IM [27] | Yes [25] | |
| Cytoplasmic peptidyl-prolyl cis-trans isomerase | CPR1 (YDR155C) | PPIF | 17.4 | – | Cytosol [28] | Yes [25] | |
| Tetrameric phosphoglycerate mutase | GPM1 (YKL152C) | PGAM2 | 27.6 | – | Cytosol, extracellular [29] | Yes [25] | |
| Homologous Mmf1p Factor , member of the p14.5 protein family | HMF1 (YER057C) | – | 13.9 | – | Cytosol [30] | Yes [25] | |
| Peroxiredoxin HYR1 | HYR1 (YIR037W) | – | 18.6 | – | Cytosol [31] | Yes [25] | |
| Mitochondrial intermembrane space cysteine motif-containing protein MIX23 | MIX23 (YBL107C) | – | 23.0 | CX14C, CX13C | – | Yes [25] | |
| Mitochondrial peculiar membrane protein 1 | MPM1 (YJL066C) | – | 28.5 | – | Mitochondrial membrane [32] | Yes [25] | |
| Mitochondrial transcription factor 1 | MTF1 (YMR228W) | – | 39.7 | – | Mitochondria [33,34] | No | |
| Carbonic anhydrase | NCE103 (YNL036W) | – | 24.9 | CX8C, CX16CX8CX4CX5CX12C | – | Yes [25] | |
| Pyridoxine phosphate oxidase | PDX3 (YBR035C) | PNPO | 26.9 | – | – | No | |
| Protein required for assembly of cytochrome c oxidase | PET191 (YJR034W) | – | 12.4 | Twin CX9C | Integral to IM facing the IMS [35] | Yes [25] | |
| 3-ketoacyl-CoA thiolase | POT1 | ACAA1 | 44.7 | CX16C | Peroxisome [36] | No | |
| Mitochondrial type 2C protein phosphatase | PTC5 (YOR090C) | PDP1 | 63.7 | – | – | Yes [25] | |
| Cytochrome b-c1 complex subunit 6 | QCR6 (YFR033C) | – | 17.3 | – | Mitochondrial membrane [37,38] | Yes [25] | |
| Lumazine synthase | RIB4 | – | 18.6 | – | – | Yes [25] | |
| Cytoplasmic thioredoxin reductase | TRR1 (YDR353W) | – | 34.2 | CX2C | Cytosol [39] | Yes [25] | |
| Cytoplasmic thioredoxin | TRX1 (YLR043C) | TXN | 11.2 | CX2C | Cytosol [39] | Yes [25] | |
| Putative glycoside hydrolase of the mitochondrial intermembrane space | YBR056W | – | 57.8 | – | – | No | |
Fig. 1The IMS proteome of mitochondria is involved in several cellular processes. These include (i) epigenetic regulation in the nucleus, (ii) apoptosis signalling, (iii) regulation of translation, (iv) lipid signalling, (v) signalling via reactive oxygen species (ROS), (vi) maintenance of redox homeostasis and (vii) regulation of metabolism and of the respiratory transport chain (RTC).